Ventricular Tachycardia Cohort

ConditionVentricular Tachycardia (VT)

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorBeijing Anzhen Hospital

About this trial

The goal of this observational study is to detect the long-term risk of a composite endpoint event in adult patients with ventricular tachycardia (VT) who are managed with catheter ablation or non-ablation management (including modern drug therapy and/or ICD therapy).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Sustained ventricular tachycardia (VT), defined as VT lasting ≥30 seconds or requiring intervention due to hemodynamic compromise within 30 seconds; or Clinically significant non-sustained VT (NSVT) where the treating clinician has determined that therapeutic intervention is necessary.

Disqualifiers

Concurrent participation in any interventional clinical trial that, in the judgment of the investigator, could interfere with the data collection or outcome assessment of this observational study.

Trial population

Patients diagnosed with ventricular tachycardia

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Intervention
Device
Treatment with intervention of catheter ablation or Implantable cardioverter defibrillator.

Treatment groups

1,500 Participants

are divided into 1 treatment group

Group A: Normal treatment1 intervention

Trial outcomes

Primary outcomes

Composite of death and recurrence of ventricular tachycardia

Time frame

1 year

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Beijing Anzhen Hospital

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: